Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES11.8838672889123.2935
Domestic EquitiesEQ - CIPLA LTD.5.976340000062.0040
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.4.518839600046.8824
Domestic EquitiesEQ - AJANTA PHARMA LTD.4.507917282946.7693
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD3.90717976340.5356
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.78425627139.2603
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.664427525038.0175
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.3.28555600034.0872
Domestic EquitiesEQ - ALKEM LABORATORIES LTD3.14806384032.6605
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.072646500031.8781
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE3.038948000031.5288
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.961725000030.7275
Domestic EquitiesEQ - SUVEN PHARMACEUTICALS LTD2.942926850730.5319
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD2.939221293030.4937
Domestic EquitiesEQ - GLAND PHARMA LTD.2.428918000025.2000
Domestic EquitiesEQ - LUPIN LTD.2.425712009125.1663
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD2.381548931224.7078
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.215312232722.9840
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD2.020719090120.9647
Domestic EquitiesEQ- GLOBAL HEALTH LTD.1.911916568519.8358
Domestic EquitiesEQ - ZYDUS LIFESCIENCES LTD1.875721908219.4600
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD1.758612432118.2453
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD1.640010000017.0150
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.5059108422715.6237
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.454868796915.0934
Domestic EquitiesEQ - PFIZER LIMITED1.45313511815.0755
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.392914967614.4512
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.1.37164283514.2298
Domestic EquitiesEQ - IPCA LABORATORIES LTD.1.350610000014.0120
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.350114000014.0070
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS1.157613716812.0097
Domestic EquitiesEQ - SAI LIFE SCIENCES LTD1.142117005711.8496
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD1.13282379211.7532
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.100018000011.4129
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD1.055810719510.9543
Domestic EquitiesEQ - AMI ORGANICS LTD0.97238922410.0877
Domestic EquitiesEQ - LAXMI DENTAL LIMITED0.88942356079.2275
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.7761896758.0524
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD0.7732580588.0219
Domestic EquitiesEQ - POLY MEDICURE LTD0.6947280007.2072
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.5735742855.9502
Domestic EquitiesEQ - CONCORD BIOTECH LTD0.4867332495.0492
Total 98.9229 1026.3176
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS1.0665 11.0648
Total 1.0665 11.0648
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.010600.1100
Total 0.0106 0.1100
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.